Another study also showed that genetic deletion of Ccl2 in the host (i.e., stromal) cells but not in cancer cells results in reduced TAM infiltration, deficient angiogenesis, and impaired tumor growth in mice that are orthotopically injected with 4T1 mammary tumor cells (61). This evidence concerns the gene CCL2 and neoplasm.